Which stocks in any sector do Indian mutual fund managers prefer most? — June 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 430 funds | 3.26% | ₹55,987 Cr |
| 2 | Divi's Laboratories Limited | 294 funds | 2.20% | ₹22,096 Cr |
| 3 | Cipla Limited | 268 funds | 2.07% | ₹23,345 Cr |
| 4 | Torrent Pharmaceuticals Limited | 255 funds | 2.81% | ₹7,414 Cr |
| 5 | Dr. Reddy's Laboratories Limited | 236 funds | 2.16% | ₹16,236 Cr |
| 6 | Lupin Limited | 228 funds | 1.85% | ₹16,909 Cr |
| 7 | Mankind Pharma Limited | 199 funds | 1.24% | ₹11,206 Cr |
| 8 | Glenmark Pharmaceuticals Limited | 190 funds | 2.18% | ₹7,979 Cr |
| 9 | Aurobindo Pharma Limited | 186 funds | 1.74% | ₹9,718 Cr |
| 10 | Laurus Labs Limited | 181 funds | 5.13% | ₹7,267 Cr |
| 11 | Ajanta Pharma Limited | 179 funds | 1.00% | ₹7,528 Cr |
| 12 | Alkem Laboratories Limited | 169 funds | 1.31% | ₹11,106 Cr |
| 13 | JB Chemicals & Pharmaceuticals Limited | 166 funds | 1.95% | ₹6,708 Cr |
| 14 | Sai Life Sciences Limited | 153 funds | 2.27% | ₹7,715 Cr |
| 15 | Biocon Limited | 150 funds | 1.17% | ₹9,536 Cr |
| 16 | Zydus Lifesciences Limited | 149 funds | 1.15% | ₹5,042 Cr |
| 17 | Abbott India Limited | 145 funds | 0.90% | ₹3,941 Cr |
| 18 | IPCA Laboratories Limited | 144 funds | 1.13% | ₹13,267 Cr |
| 19 | Anthem Biosciences Limited | 143 funds | 0.66% | ₹4,196 Cr |
| 20 | Gland Pharma Limited | 133 funds | 1.95% | ₹11,449 Cr |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of June 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.